Difference between revisions of "Part:BBa I739015"
Stefan Luzi (Talk | contribs) (→Purpose) |
|||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_I739015 short</partinfo> | <partinfo>BBa_I739015 short</partinfo> | ||
− | + | ===Part Structure=== | |
+ | <p>The Biobrick encodes [https://parts.igem.org/wiki/index.php/Help:Tag LVA]-tagged P22 cII ([https://parts.igem.org/wiki/index.php/Part:BBa_C0053 BBa_C0053]) and untagged EYFP ([https://parts.igem.org/wiki/index.php/Part:BBa_E0030 BBa_E0030]) under control of the double promoter [https://parts.igem.org/wiki/index.php/Part:BBa_I739102 BBa_I739102]. The ribosome binding sites [https://parts.igem.org/wiki/index.php/Part:BBa_B0034 BBa_B0034] are located upstream of each coding region. The transcription of P22 cII and EYFP is terminated by the double terminator [https://parts.igem.org/wiki/index.php/Part:BBa_B0015 BBa_B0015].</p> | ||
+ | |||
+ | ===Mode of Action=== | ||
+ | <p>P22 cII and EYFP production can be repressed by cI and/or TetR. If the inducer [http://openwetware.org/wiki/ATc anhydrotetracycline (ATc)] is added, tetR action is inhibited and the promoter gets derepressed. However, there is no inducer available which neutralizes the action of cI. </p> | ||
+ | |||
+ | ===Purpose=== | ||
+ | <p>This Biobrick was designed for the [http://2007.igem.org/ETHZ ETHZ iGEM 2007 project] and belongs to the reporting part of the system. In the project description, this part is a composite of [https://parts.igem.org/wiki/index.php/Part:BBa_I739004 ''Part 4''] and [https://parts.igem.org/wiki/index.php/Part:BBa_E0430 ''Part 5new''].</p> | ||
+ | |||
+ | ===Testing=== | ||
+ | <p>Checked for uniqueness of restriction enzyme cleavage sites:<br> | ||
+ | Eco: ok<br> | ||
+ | Xba: ok<br> | ||
+ | Spe: ok<br> | ||
+ | Pst: ok<br> | ||
+ | </p> | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 19:17, 24 October 2007
Double regulated polycistronic P22 cII +LVA / EYFP -LVA expression cassette
Part Structure
The Biobrick encodes LVA-tagged P22 cII (BBa_C0053) and untagged EYFP (BBa_E0030) under control of the double promoter BBa_I739102. The ribosome binding sites BBa_B0034 are located upstream of each coding region. The transcription of P22 cII and EYFP is terminated by the double terminator BBa_B0015.
Mode of Action
P22 cII and EYFP production can be repressed by cI and/or TetR. If the inducer [http://openwetware.org/wiki/ATc anhydrotetracycline (ATc)] is added, tetR action is inhibited and the promoter gets derepressed. However, there is no inducer available which neutralizes the action of cI.
Purpose
This Biobrick was designed for the [http://2007.igem.org/ETHZ ETHZ iGEM 2007 project] and belongs to the reporting part of the system. In the project description, this part is a composite of Part 4 and Part 5new.
Testing
Checked for uniqueness of restriction enzyme cleavage sites:
Eco: ok
Xba: ok
Spe: ok
Pst: ok
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 289